Feb 22, 2024
Ha Tran, Medical Head, Cell and Gene Therapy at Astellas Pharma is developing gene therapy approaches to fight neuromuscular diseases, central nervous system disorders, and ophthalmology conditions. There is strong evidence that this approach can be a way to treat and possibly cure rare diseases. Ha explains...
Feb 22, 2024
Ha Tran, Medical Head, Cell and Gene Therapy at Astellas Pharma is developing gene therapy approaches to fight neuromuscular diseases, central nervous system disorders, and ophthalmology conditions. There is strong evidence that this approach can be a way to treat and possibly cure rare diseases. Ha explains...
Jun 14, 2023
Dr. Antonin (Tony) de Fougerolles, CEO of Evox Therapeutics, highlights that exosomes, small nanoparticles, are produced by every cell in the body. They contain RNA and proteins that the cell decides to put into the exosome, and they're secreted out into the environment and act as a way that cells communicate with each...
Jun 14, 2023
Dr. Antonin (Tony) de Fougerolles, CEO of Evox Therapeutics, highlights that exosomes, small nanoparticles, are produced by every cell in the body. They contain RNA and proteins that the cell decides to put into the exosome, and they're secreted out into the environment and act as a way that cells communicate with each...
Feb 20, 2023
Sandy Macrae, CEO of Sangamo Therapeutics, talks about the promise and limitations of genomic medicine to find the most effective and affordable treatments for patients with autoimmune and inflammatory diseases. Their CAR-Treg cell therapy platform allows T cells to be tracked throughout the body and activated to...